Primary and Secondary Progressive Aphasia in Posterior Cortical Atrophy.
Alzheimer’s disease
differential diagnosis
language impairment
logopenic variant of primary progressive aphasia
posterior cortical atrophy
Journal
Life (Basel, Switzerland)
ISSN: 2075-1729
Titre abrégé: Life (Basel)
Pays: Switzerland
ID NLM: 101580444
Informations de publication
Date de publication:
29 Apr 2022
29 Apr 2022
Historique:
received:
24
03
2022
revised:
20
04
2022
accepted:
25
04
2022
entrez:
28
5
2022
pubmed:
29
5
2022
medline:
29
5
2022
Statut:
epublish
Résumé
Posterior cortical atrophy (PCA) is a clinico-radiological syndrome characterized by a progressive decline in visuospatial/visuoperceptual processing. PCA is accompanied by the impairment of other cognitive functions, including language abilities. The present study focused on three patients presenting with language complaints and a clinical profile that was compatible with PCA. In addition to neurological and neuroimaging examinations, they were assessed with comprehensive batteries of neuropsychological and neurolinguistic tests. The general medical profile of the three patients is consistent with PCA, although they presented with confounding factors, making diagnosis less clear. The cognitive profile of the three patients was marked by Balint and Gerstmann's syndromes as well as impairments affecting executive functions, short-term and working memory, visuospatial and visuoperceptual abilities, and sensorimotor execution abilities. Their language ability was characterized by word-finding difficulties and impairments of sentence comprehension, sentence repetition, verbal fluency, narrative speech, reading, and writing. This study confirmed that PCA is marked by visuospatial and visuoperceptual deficits and reported evidence of primary and secondary language impairments in the three patients. The similarities of some of their language impairments with those found in the logopenic variant of primary progressive aphasia is discussed from neurolinguistic and neuroanatomical points of view.
Sections du résumé
BACKGROUND
BACKGROUND
Posterior cortical atrophy (PCA) is a clinico-radiological syndrome characterized by a progressive decline in visuospatial/visuoperceptual processing. PCA is accompanied by the impairment of other cognitive functions, including language abilities.
METHODS
METHODS
The present study focused on three patients presenting with language complaints and a clinical profile that was compatible with PCA. In addition to neurological and neuroimaging examinations, they were assessed with comprehensive batteries of neuropsychological and neurolinguistic tests.
RESULTS
RESULTS
The general medical profile of the three patients is consistent with PCA, although they presented with confounding factors, making diagnosis less clear. The cognitive profile of the three patients was marked by Balint and Gerstmann's syndromes as well as impairments affecting executive functions, short-term and working memory, visuospatial and visuoperceptual abilities, and sensorimotor execution abilities. Their language ability was characterized by word-finding difficulties and impairments of sentence comprehension, sentence repetition, verbal fluency, narrative speech, reading, and writing.
CONCLUSIONS
CONCLUSIONS
This study confirmed that PCA is marked by visuospatial and visuoperceptual deficits and reported evidence of primary and secondary language impairments in the three patients. The similarities of some of their language impairments with those found in the logopenic variant of primary progressive aphasia is discussed from neurolinguistic and neuroanatomical points of view.
Identifiants
pubmed: 35629330
pii: life12050662
doi: 10.3390/life12050662
pmc: PMC9142989
pii:
doi:
Types de publication
Case Reports
Langues
eng
Références
Cortex. 2012 Nov-Dec;48(10):1288-97
pubmed: 22079684
Cortex. 2007 Feb;43(2):264-70
pubmed: 17405672
Front Neurol. 2017 Aug 16;8:389
pubmed: 28861031
J Mol Neurosci. 2011 Nov;45(3):724-36
pubmed: 21710364
BMC Neurol. 2018 May 10;18(1):65
pubmed: 29747584
Arch Clin Neuropsychol. 2010 May;25(3):212-7
pubmed: 20197296
J Neurol Sci. 2010 Jan 15;288(1-2):25-33
pubmed: 19896678
Alzheimers Dement. 2017 Aug;13(8):870-884
pubmed: 28259709
Neurodegener Dis Manag. 2019 Aug;9(4):217-239
pubmed: 31392920
Neurocase. 2003 Jun;9(3):251-60
pubmed: 12925931
Behav Neurol. 2011;24(3):229-36
pubmed: 21876262
Hum Brain Mapp. 2007 Mar;28(3):205-17
pubmed: 16767767
Rev Neurol (Paris). 2009 Jun-Jul;165(6-7):560-7
pubmed: 19150097
Brain. 2013 Mar;136(Pt 3):844-58
pubmed: 23358601
Cortex. 2017 Aug;93:92-106
pubmed: 28624681
Arch Clin Neuropsychol. 2016 Nov 22;31(7):819-826
pubmed: 27625048
J Clin Neuropsychol. 1984 Nov;6(4):433-40
pubmed: 6501581
Q J Exp Psychol A. 1995 Aug;48(3):573-97
pubmed: 7568992
Brain Sci. 2021 Jun 19;11(6):
pubmed: 34205444
Neurology. 2006 Feb 14;66(3):331-8
pubmed: 16476930
Neurology. 2004 Oct 12;63(7):1168-74
pubmed: 15477533
Curr Opin Neurol. 2010 Dec;23(6):633-7
pubmed: 20852419
Neuroimage Clin. 2019;23:101889
pubmed: 31200149
J Neurol Neurosurg Psychiatry. 1991 May;54(5):443-8
pubmed: 1865209
Cortex. 2018 Sep;106:36-46
pubmed: 29864594
Neurology. 2009 Nov 10;73(19):1571-8
pubmed: 19901249
Neurobiol Aging. 2012 Apr;33(4):744-52
pubmed: 20580129
Neurology. 2011 Mar 15;76(11):1006-14
pubmed: 21325651
Front Psychol. 2018 Aug 03;9:1345
pubmed: 30123155
Philos Trans R Soc Lond B Biol Sci. 1982 Jun 25;298(1089):199-209
pubmed: 6125971
Neurologist. 2019 Mar;24(2):62-65
pubmed: 30817493
Neuropsychiatry Neuropsychol Behav Neurol. 1997 Jan;10(1):52-9
pubmed: 9118197
Neuropsychologia. 2019 Aug;131:216-222
pubmed: 31095931
Clin Neuropsychol. 2016 Oct;30(7):1126-50
pubmed: 27279436
Ann Neurol. 2018 Nov;84(5):729-740
pubmed: 30255971
Case Rep Neurol. 2019 May 8;11(2):157-166
pubmed: 31543797
Dement Geriatr Cogn Disord. 2021;50(2):195-203
pubmed: 34274933
J Neurol Neurosurg Psychiatry. 2013 Apr;84(4):460-6
pubmed: 23138762
Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2018 Sep;25(5):753-766
pubmed: 28853339
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
Front Psychol. 2017 Mar 06;8:269
pubmed: 28321196
Neurology. 2003 Oct 28;61(8):1134-5
pubmed: 14581681
Arch Neurol. 1988 Jul;45(7):789-93
pubmed: 3390033
Nat Rev Neurol. 2014 Oct;10(10):554-69
pubmed: 25179257
J Neurol. 2013 Feb;260(2):528-33
pubmed: 23007194
J Alzheimers Dis. 2018;66(3):1015-1025
pubmed: 30372673
Neurol Sci. 2019 Aug;40(8):1713-1716
pubmed: 30963338
Neurology. 2004 Oct 12;63(7):1175-80
pubmed: 15477534
Neuropsychologia. 2020 Mar 16;140:107391
pubmed: 32057937
Cortex. 2015 Oct;71:183-9
pubmed: 26232551
Hum Brain Mapp. 2015 Nov;36(11):4421-37
pubmed: 26260856
Brain. 2019 Jul 1;142(7):2082-2095
pubmed: 31219516
Cognition. 2004 May-Jun;92(1-2):145-77
pubmed: 15037129
J Alzheimers Dis. 2021;82(2):493-502
pubmed: 34057092
Neurology. 2008 Oct 14;71(16):1227-34
pubmed: 18633132
Lancet Neurol. 2012 Feb;11(2):170-8
pubmed: 22265212
Arch Clin Neuropsychol. 2016 Dec 1;31(8):926-933
pubmed: 27246959
Cereb Cortex. 2012 Aug;22(8):1894-903
pubmed: 21955921
Brain. 2011 May;134(Pt 5):1464-78
pubmed: 21478188
J Speech Lang Hear Res. 2019 Aug 15;62(8):2723-2749
pubmed: 31390290
J Neurol Sci. 2016 Feb 15;361:220-8
pubmed: 26810547
Clin Neuropsychol. 2018 Jan-Dec;32(sup1):77-90
pubmed: 29726305
Neurobiol Aging. 2007 Jul;28(7):1051-61
pubmed: 16797786
Neuropsychologia. 2017 Jan 8;94:61-74
pubmed: 27913156
Dement Geriatr Cogn Disord. 2002;14(1):33-40
pubmed: 12053130
Cortex. 2019 Jun;115:133-158
pubmed: 30822613
Neuropsychologia. 2017 Oct;105:70-83
pubmed: 28057458